KalVista Pharmaceuticals, Inc.
KALV
$19.56
-$1.30-6.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.37M | -- | -60.10M | -52.23M | -48.51M |
| Total Depreciation and Amortization | 586.50K | -- | 252.00K | 261.00K | 229.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.32M | -- | 10.04M | 62.00K | 10.01M |
| Change in Net Operating Assets | -12.98M | -- | -4.70M | 11.54M | 5.59M |
| Cash from Operations | 4.55M | -- | -54.50M | -40.36M | -32.68M |
| Capital Expenditure | -697.50K | -- | -290.00K | -281.00K | -24.00K |
| Sale of Property, Plant, and Equipment | -12.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 8.86M | -- | 21.55M | -3.05M | 8.54M |
| Cash from Investing | 8.15M | -- | 21.26M | -3.33M | 8.52M |
| Total Debt Issued | 69.14M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 1.29M | 1.85M | 56.54M |
| Repurchase of Common Stock | -810.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 11.25M | -- | 21.92M | 2.81M | 95.23M |
| Cash from Financing | 79.57M | -- | 23.21M | 4.66M | 151.77M |
| Foreign Exchange rate Adjustments | -6.79M | -- | 2.72M | 3.36M | -1.25M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.49M | -- | -7.31M | -35.67M | 126.36M |